SEARCH

SEARCH BY CITATION

References

  • 1
    Smith RA, Mettlin CJ, Davis KJ, Eyre H. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 2000; 50: 3449.
  • 2
    Smith RA, Saslow D, Sawyer KA, et al. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin 2003; 53: 141169.
  • 3
    Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007; 57: 7589.
  • 4
    Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002; 52: 342362.
  • 5
    Saslow D, Castle PE, Cox JT, et al. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin 2007; 57: 728.
  • 6
    Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001—testing for early lung cancer detection. CA Cancer J Clin 2001; 51: 3875.
  • 7
    Levin B, Brooks D, Smith RA, Stone A. Emerging technologies in screening for colorectal cancer: CT colonography, immunochemical fecal occult blood tests, and stool screening using molecular markers. CA Cancer J Clin 2003; 53: 4455.
  • 8
    Rex DK, Kahi CJ, Levin B, et al. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2006; 130: 18651871.
  • 9
    Winawer SJ, Zauber AG, Fletcher RH, et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin 2006; 56: 143159.
  • 10
    Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008; 58: 130160.
  • 11
    Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 4366.
  • 12
    Tabár L, Duffy SW, Vitak B, et al. The natural history of breast carcinoma: what have we learned from screening? Cancer 1999; 86: 449462.
  • 13
    Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA 2001; 285: 27502756.
  • 14
    Hartman AR. The problems with risk selection; scientific and psychosocial aspects. Recent Results Cancer Res 2005; 166: 125144.
  • 15
    Ramsey SD, Yoon P, Moonesinghe R, Khoury MJ. Population-based study of the prevalence of family history of cancer: implications for cancer screening and prevention. Genet Med 2006; 8: 571575.
  • 16
    Murff HJ, Byrne D, Syngal S. Cancer risk assessment: quality and impact of the family history interview. Am J Prev Med 2004; 27: 239245.
  • 17
    Murff HJ, Greevy RA, Syngal S. The comprehensiveness of family cancer history assessments in primary care. Community Genet 2007; 10: 174180.
  • 18
    Sabatino SA, McCarthy EP, Phillips RS, Burns RB. Breast cancer risk assessment and management in primary care: provider attitudes, practices, and barriers. Cancer Detect Prev 2007; 31: 375383.
  • 19
    Franco EL, Schlecht NF, Saslow D. The epidemiology of cervical cancer. Cancer J 2003; 9: 348359.
  • 20
    USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary. MMWR Recomm Rep 1995; 44: 134.
  • 21
    Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale—update based on new evidence. Gastroenterology 2003; 124: 544560.
  • 22
    US Preventive Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med 2002; 137: 129131.
  • 23
    Mysliwiec PA, Brown ML, Klabunde CN, Ransohoff DF. Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann Intern Med 2004; 141: 264271.
  • 24
    Ko CW, Riffle S, Shapiro JA, et al. Incidence of minor complications and time lost from normal activities after screening or surveillance colonoscopy. Gastrointest Endosc 2007; 65: 648656.
  • 25
    Zitzelsberger L, Grunfeld E, Graham ID. Family physicians' perspectives on practice guidelines related to cancer control. BMC Fam Pract 2004; 5: 25.
  • 26
    Allison JE, Lawson M. Screening tests for colorectal cancer: a menu of options remains relevant. Curr Oncol Rep 2006; 8: 492498.
  • 27
    Leard LE, Savides TJ, Ganiats TG. Patient preferences for colorectal cancer screening. J Fam Pract 1997; 45: 211218.
  • 28
    Meissner HI, Breen N, Klabunde CN, Vernon SW. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev 2006; 15: 389394.
  • 29
    Collins JF, Lieberman DA, Durbin TE, Weiss DG. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Ann Intern Med 2005; 142: 8185.
  • 30
    Nadel MR, Shapiro JA, Klabunde CN, et al. A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med 2005; 142: 8694.
  • 31
    American College of Radiology Imaging Network. ACRIN Protocol 6656. Computerized Tomographic Colonography: Performance Evaluation in a Multicenter Setting. Available at: http://www.acrin.org/6656_protocol.html. Accessed July 1, 2007.
  • 32
    Rex DK, Kahi CJ, Levin B, et al. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and US Multi-Society Task Force on Colorectal Cancer. CA Cancer J Clin 2006; 56: 160167.
  • 33
    Walker JL, Nunez ER. Endometrial cancer, in KramerBS, GohaganJK, ProrokPC (eds). Cancer Screening: Theory and Practice. New York, NY: Marcel Dekker, Inc.; 1999: 531566.
  • 34
    Eddy D. Guidelines for the cancer related checkup: recommendations and rationale. CA Cancer J Clin 1980; 30: 194240.
  • 35
    Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999; 354: 99105.
  • 36
    Ford LG, Minasian LM, McCaskill-Stevens W, et al. Prevention and early detection clinical trials: opportunities for primary care providers and their patients. CA Cancer J Clin 2003; 53: 82101.
  • 37
    Pastorino U, Bellomi M, Landoni C, et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 2003; 362: 593597.
  • 38
    Henschke CI, Yankelevitz DF, Libby DM, et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006; 355: 17631771.
  • 39
    Maciosek MV, Coffield AB, Edwards NM, et al. Priorities among effective clinical preventive services: results of a systematic review and analysis. Am J Prev Med 2006; 31: 5261.
  • 40
    Health, United States, 2006 with Chartbook on Trends in the Health of Americans. Hyattsville, MD: National Center for Health Statistics; 2006.
  • 41
    Lieberman DA, Weiss DG. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 2001; 345: 555560.
  • 42
    Hiatt RA, Klabunde C, Breen N, et al. Cancer screening practices from National Health Interview Surveys: past, present, and future. J Natl Cancer Inst 2002; 94: 18371846.
  • 43
    Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System Public Use Data Tape 2006. Atlanta, GA: National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention; 2006.
  • 44
    Research Triangle Institute. SUDAAN: Professional software for survey data analysis: user documentation for Release 9.0. Research Triangle Park, NC: Research Triangle Institute; 2004.
  • 45
    Nelson DE, Powell-Griner E, Town M, Kovar MG. A comparison of national estimates from the National Health Interview Survey and the Behavioral Risk Factor Surveillance System. Am J Public Health 2003; 93: 13351341.
  • 46
    The Regents of the University of California. California Health Interview Survey. Available at: http://www.chis.ucla.edu/. Accessed November 14, 2007.
  • 47
    McCracken M, Olsen M, Chen MS, Jr, et al. Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin 2007; 57: 190205.
  • 48
    Breen N, A Cronin K, Meissner HI, et al. Reported drop in mammography: is this cause for concern? Cancer 2007; 109: 24052409.
  • 49
    Cram P, Fendrick AM, Inadomi J, et al. The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect. Arch Intern Med 2003; 163: 16011605.
  • 50
    Saraiya M, Hall HI, Thompson T, et al. Skin cancer screening among U.S. adults from 1992, 1998, and 2000 National Health Interview Surveys. Prev Med 2004; 39: 308314.
  • 51
    Robertson RH, Burkhardt JH, Powell MP, et al. Trends in colon cancer screening procedures in the US Medicare and Tricare populations: 1999–2001. Prev Med 2006; 42: 460462.
  • 52
    Cooper GS, Koroukian SM. Geographic variation among Medicare beneficiaries in the use of colorectal carcinoma screening procedures. Am J Gastroenterol 2004; 99: 15441550.
    Direct Link:
  • 53
    McFall SL. US men discussing prostate-specific antigen tests with a physician. Ann Fam Med 2006; 4: 433436.
  • 54
    Chan EC, Vernon SW, O'Donnell FT, et al. Informed consent for cancer screening with prostate-specific antigen: how well are men getting the message? Am J Public Health 2003; 93: 779785.
  • 55
    Woolf SH, Krist AH, Johnson RE, Stenborg PS. Unwanted control: how patients in the primary care setting decide about screening for prostate cancer. Patient Educ Couns 2005; 56: 116124.
  • 56
    Lawson HW, Henson R, Bobo JK, Kaeser MK. Implementing recommendations for the early detection of breast and cervical cancer among low-income women. MMWR Recomm Rep 2000; 31: 3755.
  • 57
    Centers for Disease Control and Prevention. National Breast and Cervical Cancer Early Detection Program Fact Sheet 2004/2005. Atlanta, GA: Centers for Disease Control and Prevention; 2005.
  • 58
    Carrasquillo O, Pati S. The role of health insurance on Pap smear and mammography utilization by immigrants living in the United States. Prev Med 2004; 39: 943950.
  • 59
    Gorin SS, Heck JE. Cancer screening among Latino subgroups in the United States. Prev Med 2005; 40: 515526.
  • 60
    Centers for Disease Control and Prevention. Colorectal cancer test use—Maryland, 2002–2006. MMWR Morb Mortal Wkly Rep 2007; 56: 932936.
  • 61
    Sarfaty M, Wender R. How to increase colorectal cancer screening rates in practice. CA Cancer J Clin 2007; 57: 354366.
  • 62
    Jemal A, Ward E, Thun MJ. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res 2007; 9: R28.
  • 63
    Farria DM, Schmidt ME, Monsees BS, et al. Professional and economic factors affecting access to mammography: a crisis today, or tomorrow? Results from a national survey. Cancer 2005; 104: 491498.
  • 64
    Smith RA, Cokkinides V, Eyre HJ. Cancer screening in the United States, 2007: a review of current guidelines, practices, and prospects. CA Cancer J Clin 2007; 57: 90104.
  • 65
    Carney PA, Goodrich ME, Mackenzie T, et al. Utilization of screening mammography in New Hampshire: a population-based assessment. Cancer 2005; 104: 17261732.
  • 66
    Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002; 137: 347360.
  • 67
    Taplin SH, Ichikawa L, Yood MU, et al. Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up? J Natl Cancer Inst 2004; 96: 15181527.
  • 68
    Solomon D, Breen N, McNeel T. Cervical cancer screening rates in the United States and the potential impact of implementation of screening guidelines. CA Cancer J Clin 2007; 57: 105111.
  • 69
    Eltoum IA, Roberson J. Impact of HPV testing, HPV vaccine development, and changing screening frequency on national Pap test volume: projections from the National Health Interview Survey (NHIS). Cancer 2007; 111: 3440.
  • 70
    Saraiya M, Irwin KL, Carlin L, et al. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). Cancer 2007; 110: 10241032.
  • 71
    Institute of Medicine. Coverage Matters: Insurance and Health Care. Washington, DC: National Academy Press; 2001.
  • 72
    Ward E, Halpern M, Schrag N, et al. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin 2008; 58: 931.
  • 73
    Busch SH, Duchovny N. Family coverage expansions: impact on insurance coverage and health care utilization of parents. J Health Econ 2005; 24: 876890.
  • 74
    Howe HL, Wu X, Ries LA, et al. Annual report to the nation on the status of cancer, 1975–2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer 2006; 107: 17111742.
  • 75
    James TM, Greiner KA, Ellerbeck EF, et al. Disparities in colorectal cancer screening: a guideline-based analysis of adherence. Ethn Dis 2006; 16: 228233.
  • 76
    DeNavas-Walt C, Proctor BD, Lee CH. Income, Poverty, and Health Insurance Coverage in the United States: 2004. Washington, DC: US Government Printing Office; 2005.
  • 77
    US Preventive Services Task Force. Guide to Clinical Preventive Services. 3rd ed. Periodic Update. Washington, DC: Agency for Healthcare Research and Quality; 2004.
  • 78
    Boulware LE, Marinopoulos S, Phillips KA, et al. Systematic review: the value of the periodic health evaluation. Ann Internal Medicine 2007; 146: 289300.
  • 79
    Fenton JJ, Cai Y, Weiss NS, et al. Delivery of cancer screening: how important is the preventive health examination? Arch Intern Med 2007; 167: 580585.
  • 80
    Maciosek MV, Edwards NM, Coffield AB, et al. Priorities among effective clinical preventive services: methods. Am J Prev Med 2006; 31: 9096.
  • 81
    US Department of Health and Human Services. Healthy People 2010. 2nd ed. With Understanding and Improving Health and Objectives for Improving Health. 2 vols. Washington, DC: US Government Printing Office; 2000.